500 participants: An important milestone for our Heart Health Study
October 2026: 500 participants have now taken part in the pilot phase of our Heart Health Study. Behind this number lie two intensive days of examinations per participant, a wide variety of measurements and tests, and a fantastic interdisciplinary study team that carries out the complex procedures with precision day after day. With the enrollment of the 500th participant, the pilot phase has reached an important milestone on the path to the large-scale main study.
A heartfelt thank you to our entire study team for their outstanding work, extensive expertise, and exceptional dedication!
We would also like to thank all participantswho, through their time, trust, and willingness to participate, make a valuable contribution to cardiovascular prevention research.
What are we researching?
Through the Heart Health Study at the Friede Springer – Cardiovascular Prevention Center (FS-CPC), we aim to better understand individual risk and protective factors and to detect cardiovascular diseases as early as possible, long before the first symptoms or clinical events occur.
To this end, we combine cardiovascular diagnostics, laboratory analyses, and state-of-the-art imaging with assessments of physical performance, cognition, and mental health. Genetic and other molecular analyses are also incorporated into our research.
The pilot phase not only provides valuable research data, but also lays the groundwork for the subsequent main study with up to 5,000 participants.
We're looking forward to the next stage!


